Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Non Operating Income (2020 - 2025)

Agilon Health (AGL) has disclosed Non Operating Income for 6 consecutive years, with $41.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 433.27% year-over-year to $41.0 million, compared with a TTM value of $67.6 million through Dec 2025, up 96.05%, and an annual FY2025 reading of $67.6 million, up 96.05% over the prior year.
  • Non Operating Income was $41.0 million for Q4 2025 at Agilon Health, up from $9.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $41.0 million in Q4 2025 and bottomed at -$1.9 million in Q4 2021.
  • Average Non Operating Income over 5 years is $8.0 million, with a median of $6.4 million recorded in 2022.
  • Peak annual rise in Non Operating Income hit 4109.46% in 2021, while the deepest fall reached 164.31% in 2021.
  • Year by year, Non Operating Income stood at -$1.9 million in 2021, then skyrocketed by 320.37% to $4.1 million in 2022, then skyrocketed by 81.86% to $7.4 million in 2023, then grew by 3.46% to $7.7 million in 2024, then skyrocketed by 433.27% to $41.0 million in 2025.
  • Business Quant data shows Non Operating Income for AGL at $41.0 million in Q4 2025, $9.4 million in Q3 2025, and $7.9 million in Q2 2025.